Overview
Aucatzyl approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). To be eligible, a person must have…
Overview
Kymriah is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat B-cell precursor acute lymphoblastic leukemia (ALL) in people up to age 25. It is also approved for some types of… read more